Thursday, October 5, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD
Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID
Presentations:
Prevalence of Carbapenemase-producing Enterobacteriaceae (CPE) in Hospital Drains and Relationship to Patient Isolates in Toronto, Canada
Alainna Jamal, Hons. BSc;
Jennie Johnstone, MD;
Kevin Katz, MD, CM, MSc, FRCPC;
Allison Mcgeer, MD, MSc;
Matthew Muller, MD, PhD;
Nadeem Khan, MD;
Vita Koren, BSc;
Angel Li, MSc;
Aimee Paterson, MSc;
Renata Souto, PhD;
Lin Tang, MBBS, MHA, MSBME, CIC;
Cameron Thomas, BSc(c);
Wil Ng, MHSc
The importance of ventilator skilled nursing facilities (vSNFs) in the regional epidemiology of carbapenemase-producing organisms (CPOs)
Michael Y. Lin, MD, MPH;
Mary Carl Froilan, RN;
Karen Lolans, BS;
Pamela Bell, BS;
David Wirth, MPH;
Sarah K. Kemble, MD;
Massimo Pacilli, MS MPH;
Stephanie R. Black, MD, MSc;
Olufemi Jegede, MPH;
Erica Runningdeer, MSN, MPH, RN;
Angela S. Tang, MPH;
Chinyere Alu, MPH;
Rachel Slayton, PhD, MPH;
Anthony E. Fiore, MD;
John A. Jernigan, MD, MS;
William E. Trick, MD;
Robert A. Weinstein, MD;
Mary K. Hayden, MD
Investigation of Epidemiology and Pathogenesis of Co-infection with Multiple Carbapenem-Resistant Enterobactereciae in Hospitalized Patients
Thomas Holowka, PhD;
Melinda Monteforte, PharmD;
Roderick Go, DO;
Bennadette Maramara, MD;
Teresa Khoo, MD;
Robert Chow, MD;
Yasin Abul, MD;
Rahul Mahapatra, DO;
Alexa Morgan, .;
Elizabeth Diago-Navarro, PhD;
Bettina C. Fries, MD, FIDSA
Molecular and Microbiological Evaluation of Carbapenem-resistant Enterobacteriaceae (CRE) at Two Centers in Texas
Ruth Serrano, MD;
Michelle Matheu, MD;
Federico Perez, MD, MS;
Jan E. Patterson, MD, MS, FIDSA, FSHEA;
Steven Dallas, PhD;
Susan D. Rudin, BS;
Robert A. Bonomo, MD;
Kristi Traugott, PharmD, BCPS;
Jose Cadena, MD/ID
Sensitivity of Different Anatomic Sites for Detection and Duration of Colonization with Carbapenemase-producing Enterobacteriaceae (CPE)
Emily Borgundvaag, MSc;
Amna Faheem, MBBS, MPH;
Shumona Shafinaz, MD;
Irene Armstrong, MD, MSc;
Brenda Coleman, PhD;
Karen Green, MSc, RN;
Kithsiri Jayasinghe, MSc;
Jennie Johnstone, MD, PhD;
Kevin Katz, MD, CM, MSc, FRCPC;
Philipp Kohler, MD;
Allison Mcgeer, MD, MSc;
Roberto Melano, PhD;
Matthew Muller, MD, PhD;
Samir Patel, PhD;
Susan Poutanen, MD, MPH, FRCPC;
Anu Rebbapragada, PhD;
David Richardson, MD;
Alicia Sarabia, MD;
Andrew E. Simor, MD, FRCPC, FACP;
Barbara Willey, ART;
Laura Wisely, RT
Clinical outcomes of patients with IMP-type carbapenemase-producing Enterobacteriaceae
Kayoko Hayakawa, MD, PhD;
Masahiro Ishikane, MD, PhD;
Kazuhisa Mezaki, MT;
Yuichi Katanami, MD;
Saho Takaya, MD, MSc;
Kei Yamamoto, M.D.;
Satoshi Kutsuna, MD, PhD;
Maki Nagashima, MT;
Yuko Sugiki, RN;
Norio Ohmagari, MD, MSc, PhD
Prevalence and Predictors of Infections Due to Carbapenem-Only Susceptible Organisms After Escalation of Antibiotic Therapy in Hospitalized Patients
Betty Vu, PharmD;
Sheila Wang, PharmD, BCPS AQ-ID;
Amy Hanson, PharmD, BCPS AQ-ID;
Payal Gurnani, PharmD, BCPS, BCCCP;
Kimberly Ackerbauer, PharmD, BCPS;
Laura Geswein, PharmD, BCOP, BCPS;
Spencer Harpe, PharmD, PhD, MPH;
Sarah Won, MD, MPH;
Christy Varughese, PharmD, BCPS
An Evaluation of Meropenem Use and Resistance in a Mixed Medical/Surgical Intensive Care Unit
Matthew Crotty, PharmD;
Tamara Reiter, PharmD, BCPS, BCCCP;
Kristen Hillebrand, PharmD, BCCCP;
Tung Tran, MD;
Edward Dominguez, MD, FACP, FIDSA
National Prevalence and Regional Variation of Carbapenem-resistant Gram-negative Bacteria in the Ambulatory and Acute Care Settings in the United States in 2016
Bin Cai, MD, PhD;
Roger Echols, MD, FIDSA;
Gareth Morgan, Ph.D;
David Van Veenhuyzen, MBChB, MPharmMed;
Mari Ariyasu, Ph.D;
Takuko Sawada, BA;
John Murray, MPH;
Tsutae Den Nagata, MD, PhD, FFPM;
Vikas Gupta, PharmD, BCPS
Modeling Carbapenem Resistance Among Gram Negative Pathogens Using Commonly Available Clinical Data
Stefan Richter, MD;
James A. McKinnell, MD;
Douglas Bell, MD, PhD;
Daniel Z. Uslan, MD, MS, FIDSA, FSHEA;
Karol Watson, MD;
Romney Humphries, PhD;
Loren Miller, MD, MPH, FIDSA
Burden of Carbapenem-resistant Gram-negative Infections in US Hospitals
Bin Cai, MD, PhD;
Roger Echols, MD, FIDSA;
Frank Corvino, PhD;
Gareth Morgan, Ph.D;
David Van Veenhuyzen, MBChB, MPharmMed;
Mari Ariyasu, Ph.D;
Takuko Sawada, BA;
Tsutae Den Nagata, MD, PhD, FFPM
Attributable Clinical and Economic Burden of Carbapenem Non-susceptible Gram-negative Infections among Patients Hospitalized with Respiratory Infections
Ying Tabak, PhD;
Anita Sung, PhD;
Richard Johannes, MD, MS;
Gang Ye, PhD;
Stephen Kurtz, MS;
Latha Vankeepuram, MS;
Vikas Gupta, PharmD, BCPS;
Eilish McCann, PhD
Comparison of epidemiology of IMP-type metallo-beta-lactamase producing carbapenem-resistant Klebsiella pneumoniae vs Enterobacter cloacae in a tertiary care hospital in Japan over 5 years
Masahiro Ishikane, MD, PhD;
Kayoko Hayakawa, MD, PhD;
Kazuhisa Mezaki, MT;
Yuichi Katanami, MD;
Saho Takaya, MD, MSc;
Maki Nagashima, MT;
Yuko Sugiki, RN;
Norio Ohmagari, MD, MSc, PhD
Mcr-1 in Connecticut: Investigations of an Emerging Resistance Gene in Two Patients, 2016–2017
Vivian Leung, MD;
Noelisa Montero, MPH;
Meghan Maloney, MPH;
Amber Vasquez, MD, MPH;
Mark Laughlin, DVM, MPH;
Ehren Dancy, MD;
Russell Melmed, MPH;
Jessica Chen, PhD;
Jason Folster, PhD;
Rebecca Lindsey, PhD;
David Lonsway, MMSc;
Sandra Boyd, BS;
Louise Francois Watkins, MD, MPH;
Maroya Spalding Walters, PhD, ScM;
Lynn Sosa, MD
Identification of Three Patients with Colistin Resistant Escherichia coli Isolates Containing the mcr-1 (Mobile Colistin Resistance) Gene from a Single Health System in Michigan, USA
Laraine L. Washer, MD;
Brenda Brennan, MSPH;
John Mills, MD;
Carolyn Dombecki, MPH, CIC;
Amanda Valyko, MPH, CIC;
Oryan Henig, MD;
Marty Soehnlen, PhD, MPH;
Kelly Jones, BS, MT, ASCP;
Keith S. Kaye, MD, MPH;
Michael A. Bachman, MD, PhD
Risk Factors for Colistin Resistance; A 10 Year Experience at a Tertiary Medical Center
Stefan Richter, MD;
James A. Mckinnell, MD;
Douglas Bell, MD, PhD;
Daniel Z. Uslan, MD, MS, FIDSA, FSHEA;
Karol Watson, MD;
Loren Miller, MD, MPH, FIDSA;
Romney Humphries, PhD
Longitudinal Analysis of ICU Surface Multidrug Resistant Organism Contamination in the US and Pakistan
Jennie H. Kwon, DO, MSCI;
Alaric D' Souza, BS;
Robert Potter, BS;
Meghan Wallace, BS;
Angela Shupe, BS;
Sanket Patel, MS;
Danish Gul, BS;
Saadia Andleeb, PhD;
Carey-Ann D. Burnham, PhD;
Gautam Dantas, PhD
Trends in the incidence of bacteremia with carbapenem non-susceptible Acinetobacter spp. in patients from the US Veterans Health Administration, 2000-2015.
Sachin Patel, MD;
Brigid Wilson, PhD;
Nadim G. El Chakhtoura, MD;
Elie Saade, MD, MPH;
Curtis J. Donskey, MD;
Robert A. Bonomo, MD;
Federico Perez, MD, MS
Characteristics and Predictive Factors for Multidrug-Resistant Gram-Negative Infection Following Deployment-Related Trauma
Wesley Campbell, MD;
Ping Li, MS;
Leigh Carson, MS;
Timothy J. Whitman, DO;
Dana M. Blyth, MD;
Joseph L. Petfield, MD;
Katrin Mende, PhD;
David R. Tribble, MD, DrPH, FIDSA
Impact of Screening/Decolonization Program on Carbapenem-Resistant Enterobacteriaceae (CRE) and Methicillin-Resistant Staphylococcus aureus (MRSA) Colonized Patients and their Subsequent Risk for Infections
Juan Diego Velez, MD;
Fernando Rosso, MD, MSc;
Ana Milena Ruiz, MD;
Marly Orrego, RN, MSC;
Nora Guarin, Pathology;
Sofia Montes, Medical Student;
Andres Lindo, Medical Student;
Eric Tafur, Medical Student
Multi-drug Resistant Organisms (MDROs) Have Escaped the Hospital: Evidence of Community Acquisition at a Regional Hospital
Nicholas Turner, MD;
Rebekah W. Moehring, MD, MPH;
Vance G. Fowler Jr., MD;
Kenneth Schmader, MD;
David J. Weber, MD, MPH;
Daniel J. Sexton, MD, FIDSA, FSHEA;
Deverick J. Anderson, MD, MPH, FIDSA, FSHEA
Active Surveillance for Carbapenem-resistant Enterobacteriaceae, Vancomycin-resistant Enterococci and toxigenic Clostridium difficile among Patients transferred from Long-term Care Facilities at a Tertiary Hospital in Korea
Joo-Hee Hwang, MD;
Jeong Su Park, MD;
Eunyoung Lee, M.D.;
Pyeong Gyun Choe, M.D.;
Wan Beom Park, MD;
Ji Hwan Bang, MD, PhD;
Sang Won Park, M.D., Ph.D.;
Nam Joong Kim, MD, PhD;
Myoung-Don Oh, M.D., Ph.D.;
Kyoung-Ho Song, MD;
Eu Suk Kim, MD;
Hong Bin Kim, MD, PhD
CME Credits: Maximum of 0.00 hours of
AMA PRA Category 1 Credit™
